(ALK-B) ALK-Abelló - Performance 23.7% in 12m
ALK-B performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
35.93%
#12 in Peer-Group
Rel. Strength
70.50%
#2188 in Stock-Universe
Total Return 12m
23.69%
#44 in Peer-Group
Total Return 5y
109.41%
#11 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 44.2 |
| P/E Forward | - |
| High / Low | DKK |
|---|---|
| 52 Week High | 187.50 DKK |
| 52 Week Low | 131.90 DKK |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 84.23 |
| Buy/Sell Signal +-5 | 0.79 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: ALK-B (23.7%) vs XBI (-10.8%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
2.52% | 66.7% | 77.4% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-11.7% | -9.92% | 139% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
-3.21% | -7.33% | 26.4% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
-0.28% | 31.9% | -4.56% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
0.91% | -10.3% | 0.26% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
12.3% | 65.1% | -9.72% | 25.5 | 22.8 | 0.91 | 48.1% | 3.93% |
| PTCT NASDAQ PTC Therapeutics |
0.02% | 56.7% | -7.85% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
2.86% | 34.5% | 14.3% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: ALK-B vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ALK-B
| Total Return (including Dividends) | ALK-B | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 2.69% | 2.09% | 4.55% |
| 3 Months | 34.65% | 2.27% | 10.78% |
| 12 Months | 23.69% | -10.84% | 14.71% |
| 5 Years | 109.41% | -26.24% | 112.53% |
| Trend Score (consistency of price movement) | ALK-B | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 30.6% | 18.8% | 79.2% |
| 3 Months | 95.9% | 71.5% | 92.9% |
| 12 Months | 0.3% | -84.3% | 44.2% |
| 5 Years | 28.3% | -52.7% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th65.50 | 0.59% | -1.78% |
| 3 Month | %th85.00 | 31.67% | 21.55% |
| 12 Month | %th79.00 | 38.73% | 7.83% |
| 5 Years | %th95.00 | 183.93% | -1.46% |
FAQs
Does ALK-Abelló (ALK-B) outperform the market?
Yes,
over the last 12 months ALK-B made 23.69%, while its related Sector, the SPDR S&P Biotech (XBI) made -10.84%.
Over the last 3 months ALK-B made 34.65%, while XBI made 2.27%.
Performance Comparison ALK-B vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
ALK-B vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -1.1% | -1.9% | 8.8% | 9% |
| US NASDAQ 100 | QQQ | -1.9% | -2.9% | 6.7% | 9% |
| German DAX 40 | DAX | -0.9% | 2.7% | -4.1% | -6% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -0.8% | -1.5% | 10.8% | 6% |
| Hongkong Hang Seng | HSI | -0.7% | -3.1% | -6.9% | -12% |
| India NIFTY 50 | INDA | -0.7% | 0.6% | 9.1% | 24% |
| Brasil Bovespa | EWZ | -2.5% | -5.1% | -15.7% | 10% |
ALK-B vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -2.6% | -4.1% | 2.2% | -5% |
| Consumer Discretionary | XLY | 0.5% | 1.1% | 17.5% | 4% |
| Consumer Staples | XLP | 2.4% | 4.3% | 10.6% | 15% |
| Energy | XLE | 3.3% | -0.8% | 14.3% | 28% |
| Financial | XLF | -1.2% | -0.4% | 5.7% | -5% |
| Health Care | XLV | -0.1% | 0.7% | 16% | 29% |
| Industrial | XLI | -0.7% | -1.1% | 2.2% | -0% |
| Materials | XLB | 0.9% | 1.1% | 9.5% | 21% |
| Real Estate | XLRE | 3.4% | 2.7% | 11.5% | 11% |
| Technology | XLK | -2.4% | -6.2% | 5.6% | 12% |
| Utilities | XLU | 1.3% | 2.6% | 5.5% | -1% |
| Aerospace & Defense | XAR | -3% | -7.2% | -12.6% | -29% |
| Biotech | XBI | 1.1% | 0.6% | 22.8% | 35% |
| Homebuilder | XHB | 0.7% | -3.4% | 20.1% | 23% |
| Retail | XRT | 2% | 1.3% | 17.5% | 18% |
ALK-B vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 6.2% | -2.43% | 18.1% | 34% |
| Natural Gas | UNG | 11.1% | 12.1% | 24% | 31% |
| Gold | GLD | 3.9% | 4.9% | -11% | -18% |
| Silver | SLV | 2.3% | -1.2% | -9.7% | 1% |
| Copper | CPER | -1.4% | -1.5% | -10.9% | 8% |
ALK-B vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 0.1% | -0.9% | 12% | 22% |
| iShares High Yield Corp. Bond | HYG | 1% | 0.8% | 9.8% | 13% |